• Patent Title: Lactobacillus fermentum for treating fructose-related diseases
  • Application No.: US17040019
    Application Date: 2019-03-12
  • Publication No.: US11318177B2
    Publication Date: 2022-05-03
  • Inventor: Jorg PauleFabio Oester
  • Applicant: AIXSWISS B.V.
  • Applicant Address: NL Kerkrade
  • Assignee: AIXSWISS B.V.
  • Current Assignee: AIXSWISS B.V.
  • Current Assignee Address: NL Kerkrade
  • Agency: Cantor Colburn LLP
  • Agent Bryan D. Zerhusen, Esq.; Nicholas R. Herrel, Esq.
  • Priority: EP18163018 20180321
  • International Application: PCT/EP2019/056126 WO 20190312
  • International Announcement: WO2019/179823 WO 20190926
  • Main IPC: A01N63/00
  • IPC: A01N63/00 A61K35/747 A61P1/00 A61K9/00
Lactobacillus fermentum for treating fructose-related diseases
Abstract:
The present invention is directed to a composition of Lactobacillus fermentum for use in the treatment of a fructose-related disease and a related method of treatment.
Public/Granted literature
Information query
Patent Agency Ranking
0/0